We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Intercept Pharmaceuticals is a biotech company focused on developing and commercializing novel therapeutics to treat chronic liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor. Intercept Pharmaceuticals is a biotech company focused on developing and commercializing novel therapeutics to treat chronic liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor.
sNDA intended to satisfy post-marketing requirements to confirm a clinical benefit in patients with PBCPrecedent-setting submission includes data from post-marketing studies COBALT and Study 401...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0.37 | 1.98604401503 | 18.63 | 19.02 | 18.6 | 1567134 | 18.92212417 | CS |
52 | 0.04 | 0.210970464135 | 18.96 | 19.39 | 8.8216 | 1652740 | 14.95815484 | CS |
156 | -1.33 | -6.54205607477 | 20.33 | 22.36 | 8.8216 | 1047416 | 15.88920532 | CS |
260 | -68.69 | -78.3327631429 | 87.69 | 125 | 8.8216 | 927419 | 30.97639884 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions